Cargando…

The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics

BACKGROUND: Inappropriate overuse of antibiotics contributes to antimicrobial resistance (AMR), yet policy implementation to reduce inappropriate antibiotic use is poor in low and middle-income countries. AIMS: To determine whether public sector inappropriate antibiotic use is lower in countries rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Holloway, Kathleen Anne, Rosella, Laura, Henry, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803297/
https://www.ncbi.nlm.nih.gov/pubmed/27002977
http://dx.doi.org/10.1371/journal.pone.0152020
_version_ 1782422861469712384
author Holloway, Kathleen Anne
Rosella, Laura
Henry, David
author_facet Holloway, Kathleen Anne
Rosella, Laura
Henry, David
author_sort Holloway, Kathleen Anne
collection PubMed
description BACKGROUND: Inappropriate overuse of antibiotics contributes to antimicrobial resistance (AMR), yet policy implementation to reduce inappropriate antibiotic use is poor in low and middle-income countries. AIMS: To determine whether public sector inappropriate antibiotic use is lower in countries reporting implementation of selected essential medicines policies. MATERIALS AND METHODS: Results from independently conducted antibiotic use surveys in countries that did, and did not report implementation of policies to reduce inappropriate antibiotic prescribing, were compared. Survey data on four validated indicators of inappropriate antibiotic use and 16 self-reported policy implementation variables from WHO databases were extracted. The average difference for indicators between countries reporting versus not reporting implementation of specific policies was calculated. For 16 selected policies we regressed the four antibiotic use variables on the numbers of policies the countries reported implementing. RESULTS: Data were available for 55 countries. Of 16 policies studied, four (having a national Ministry of Health unit on promoting rational use of medicines, a national drug information centre and provincial and hospital drugs and therapeutics committees) were associated with statistically significant reductions in antibiotic use of ≥20% in upper respiratory infection (URTI). A national strategy to contain antibiotic resistance was associated with a 30% reduction in use of antibiotics in acute diarrheal illness. Policies seemed to be associated with greater effects in antibiotic use for URTI and diarrhea compared with antibiotic use in all patients. There were negative correlations between the numbers of policies reported implemented and the percentage of acute diarrhoea cases treated with antibiotics (r = -0.484, p = 0.007) and the percentage of URTI cases treated with antibiotics (r = -0.472, p = 0.005). Major study limitations were the reliance on self-reported policy implementation data and antibiotic use data from linited surveys. CONCLUSIONS: Selected essential medicines policies were associated with lower antibiotic use in low and middle income countries.
format Online
Article
Text
id pubmed-4803297
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48032972016-03-25 The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics Holloway, Kathleen Anne Rosella, Laura Henry, David PLoS One Research Article BACKGROUND: Inappropriate overuse of antibiotics contributes to antimicrobial resistance (AMR), yet policy implementation to reduce inappropriate antibiotic use is poor in low and middle-income countries. AIMS: To determine whether public sector inappropriate antibiotic use is lower in countries reporting implementation of selected essential medicines policies. MATERIALS AND METHODS: Results from independently conducted antibiotic use surveys in countries that did, and did not report implementation of policies to reduce inappropriate antibiotic prescribing, were compared. Survey data on four validated indicators of inappropriate antibiotic use and 16 self-reported policy implementation variables from WHO databases were extracted. The average difference for indicators between countries reporting versus not reporting implementation of specific policies was calculated. For 16 selected policies we regressed the four antibiotic use variables on the numbers of policies the countries reported implementing. RESULTS: Data were available for 55 countries. Of 16 policies studied, four (having a national Ministry of Health unit on promoting rational use of medicines, a national drug information centre and provincial and hospital drugs and therapeutics committees) were associated with statistically significant reductions in antibiotic use of ≥20% in upper respiratory infection (URTI). A national strategy to contain antibiotic resistance was associated with a 30% reduction in use of antibiotics in acute diarrheal illness. Policies seemed to be associated with greater effects in antibiotic use for URTI and diarrhea compared with antibiotic use in all patients. There were negative correlations between the numbers of policies reported implemented and the percentage of acute diarrhoea cases treated with antibiotics (r = -0.484, p = 0.007) and the percentage of URTI cases treated with antibiotics (r = -0.472, p = 0.005). Major study limitations were the reliance on self-reported policy implementation data and antibiotic use data from linited surveys. CONCLUSIONS: Selected essential medicines policies were associated with lower antibiotic use in low and middle income countries. Public Library of Science 2016-03-22 /pmc/articles/PMC4803297/ /pubmed/27002977 http://dx.doi.org/10.1371/journal.pone.0152020 Text en © 2016 Holloway et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Holloway, Kathleen Anne
Rosella, Laura
Henry, David
The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics
title The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics
title_full The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics
title_fullStr The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics
title_full_unstemmed The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics
title_short The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics
title_sort impact of who essential medicines policies on inappropriate use of antibiotics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803297/
https://www.ncbi.nlm.nih.gov/pubmed/27002977
http://dx.doi.org/10.1371/journal.pone.0152020
work_keys_str_mv AT hollowaykathleenanne theimpactofwhoessentialmedicinespoliciesoninappropriateuseofantibiotics
AT rosellalaura theimpactofwhoessentialmedicinespoliciesoninappropriateuseofantibiotics
AT henrydavid theimpactofwhoessentialmedicinespoliciesoninappropriateuseofantibiotics
AT hollowaykathleenanne impactofwhoessentialmedicinespoliciesoninappropriateuseofantibiotics
AT rosellalaura impactofwhoessentialmedicinespoliciesoninappropriateuseofantibiotics
AT henrydavid impactofwhoessentialmedicinespoliciesoninappropriateuseofantibiotics